A recent study demonstrated that EA improved the insulin resistance score compared with the control group in PCOS patients, and the protective effect of EA might be through an upregulation of the IRS-1/PI3K/GLUT4 signaling pathway (64). The gene discussed is IRS1; the disease is Insulin resistance.